PDT Partners’s PhenomeX Inc. Common Stock CELL Stock Holding History

PDT Partners’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-58,134	Closed	-$156K	–	749
2022 Q4	$156K	Sell	58,134 -91,279	-61%	-$241K	0.03%	559
2022 Q3	$427K	Sell	149,413 -121,127	-45%	-$515K	0.06%	480
2022 Q2	$1.34M	Buy	270,540 +52,812	+24%	+$277K	0.12%	287
2022 Q1	$1.55M	Buy	217,728 +75,746	+53%	+$627K	0.13%	235
2021 Q4	$2.58M	Sell	141,982 -39,778	-22%	-$858K	0.2%	187
2021 Q3	$3.56M	Buy	181,760 +77,960	+75%	+$2.96M	0.26%	180
2021 Q2	$4.65M	Buy	103,800 +57,287	+123%	+$2.66M	0.31%	111
2021 Q1	$2.34M	Buy	+46,513	New	+$3.17M	0.17%	243

Other funds holding CELL

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

NIMC

Nierenberg Investment Management Company Camas, Washington $201M AUM 36.3% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

PDT Partners's CELL Position: Q1 2023 in Review

PDT Partners sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2023, closing a stake of 58,134 shares — an estimated $156K sold.

PDT Partners first reported a position in CELL in Q1 2021 and held it in 8 quarters. The position peaked at $4.65M in Q2 2021. 102 funds tracked by Wall St. Rank hold CELL as of Q1 2023.

PDT Partners reported no remaining PhenomeX Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
PDT Partners sold 58,134 PhenomeX Inc. Common Stock shares in Q1 2023, an estimated $156K.
PDT Partners first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 8 quarters.
PDT Partners's PhenomeX Inc. Common Stock position peaked at $4.65M in Q2 2021.
102 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2023.

Based on PDT Partners's 13F filing for Q1 2023, filed 15 May 2023.